Medicare Enrolled
Dr. David Schmidt, MD
Cardiovascular Disease · Oxnard, CA
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schmidt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schmidt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schmidt
Dr. David Schmidt is a cardiovascular disease specialist in Oxnard, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schmidt performed 8,636 Medicare services across 3,986 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schmidt received a total of $47,997 from 36 pharmaceutical and/or device companies across 515 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schmidt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in CA
$47,997 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,636
Medicare services
Top 8% in CA for cardiovascular disease
3,986
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~432 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,168 | $146 | $300 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
968 | $40 | $110 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
860 | $34 | $95 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
623 | $12 | $66 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
601 | $43 | $124 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
524 | $54 | $144 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
476 | $43 | $88 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
475 | $107 | $175 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
459 | $174 | $929 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
374 | $47 | $119 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 234 | $417 | $1,000 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
209 | $18 | $65 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
157 | $172 | $570 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
144 | $21 | $85 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
139 | $20 | $45 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
129 | $62 | $373 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
109 | $202 | $998 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
92 | $61 | $400 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
85 | $24 | $90 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
78 | $1,747 | $3,500 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
78 | $124 | $400 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
68 | $101 | $388 |
| New patient office visit, complex (60-74 min) | 66 | $178 | $380 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
47 | $22 | $75 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
47 | $804 | $1,500 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
46 | $11 | $35 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
46 | $20 | $60 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
43 | $43 | $220 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
43 | $21 | $230 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
38 | $1,359 | $4,000 |
| Technetium Tc-99m pyrophosphate diagnostic injection A diagnostic injection of Technetium Tc-99m pyrophosphate used for imaging studies. The dose administered is up to 25 millicuries. |
27 | $46 | $150 |
| SPECT nuclear medicine scan, 1 area A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body. |
26 | $333 | $1,200 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
25 | $177 | $350 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
24 | $76 | $370 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
23 | $73 | $140 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
22 | $178 | $660 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
20 | $11 | $35 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
18 | $22 | $60 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
13 | $168 | $425 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
12 | $412 | $2,560 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.2% high complexity
13.2% medium
79.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,997
Total received (2018-2024)
Avg $6,857/year across 7 years
Top 10% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
515
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39,411 (82.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,586 (17.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,680
2023
$1,049
2022
$6,334
2021
$7,892
2020
$1,709
2019
$15,231
2018
$14,102
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$160
Novartis Pharmaceuticals Corporation
$147
PFIZER INC.
$140
Lexicon Pharmaceuticals, Inc.
$136
Actelion Pharmaceuticals US, Inc.
$134
Kiniksa Pharmaceuticals International, plc
$127
Medtronic, Inc.
$126
Amgen Inc.
$124
AstraZeneca Pharmaceuticals LP
$117
Merck Sharp & Dohme LLC
$110
Novo Nordisk Inc
$88
Janssen Pharmaceuticals, Inc
$86
Alnylam Pharmaceuticals Inc.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Regeneron Healthcare Solutions, Inc.
$24
SCPHARMACEUTICALS INC.
$18
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Top 3 companies account for 26.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$39,294
Novartis Pharmaceuticals Corporation
$1,306
Amgen Inc.
$1,265
Actelion Pharmaceuticals US, Inc.
$726
Amarin Pharma Inc.
$627
AstraZeneca Pharmaceuticals LP
$474
Abbott Laboratories
$471
E.R. Squibb & Sons, L.L.C.
$470
PFIZER INC.
$395
Gilead Sciences, Inc.
$325
Merck Sharp & Dohme LLC
$311
SANOFI-AVENTIS U.S. LLC
$228
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$207
Boston Scientific Corporation
$176
Medtronic, Inc.
$149
ABIOMED
$139
Regeneron Healthcare Solutions, Inc.
$138
Lexicon Pharmaceuticals, Inc.
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$132
Kiniksa Pharmaceuticals International, plc
$127
Medtronic Vascular, Inc.
$121
Novo Nordisk Inc
$112
AtriCure, Inc.
$111
Kiniksa Pharmaceuticals, Ltd.
$101
Alnylam Pharmaceuticals Inc.
$94
Lundbeck LLC
$64
Allergan Inc.
$62
Otsuka America Pharmaceutical, Inc.
$42
Bardy Diagnostics, Inc.
$42
Kowa Pharmaceuticals America, Inc.
$36
Edwards Lifesciences Corporation
$26
AngioDynamics, Inc.
$20
HeartFlow, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
G Medical Diagnostic Services, Inc.
$18
SCPHARMACEUTICALS INC.
$18
Top 3 companies account for 87.2% of all-time payments
Associated products mentioned in payments ›
ACCOLADE SR · ANDEXXA · ATRICURE ATRICLIP LAA EXCLUSION · AVEIR · Adempas · Anthem CRT Pacemaker · Arcalyst · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Confirm Rx · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FUROSCIX · HeartMate 3 Left Ventricular Dev · Impella · Inpefa · JARDIANCE · LEQVIO · LifeVest · Livalo · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · NORTHERA · ONPATTRO · OPSUMIT · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · Reveal XT · SAMSCA · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
45
Per 100K population
5.4
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schmidt is a remote & cardiac specialist, with above-average Medicare volume (top 8% in CA), with speaking/promotional industry engagement in the top 10% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schmidt experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Schmidt performed 1,168 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schmidt receive payments from pharmaceutical companies?
Yes. Dr. Schmidt received a total of $47,997 from 36 companies across 515 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schmidt's costs compare to other cardiologists in Oxnard?
Dr. Schmidt's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schmidt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Oxnard
Browse cardiologists in Oxnard ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology